Subjects were identified from the database in three centers from January 2014 to October 2019 using the following inclusion and exclusion criteria. The inclusion criteria were set as follows: 1) female participants aged between 20 and 45 years, 2) participants with serum AMH measurement within 12 months before undergoing IVF/ICSI cycles. The participants were excluded if they met the following criteria: 1) participants who underwent pre-implantation genetic testing (PGT), 2) participants using donor semen or donor oocyte, 3) mixed transfers with embryos retrieved from different oocyte retrieval cycles, 4) women with severe chronic diseases, 5) women for whom main data were missing or who were lost to follow-up. The participants were categorized into three groups according to the <25th(low), 25th to 75th(average), and >75th(high) percentile of serum AMH concentration (0.01-1.76, 1.76-5.41, 5.41-25.00ng/ml). The subgroup analysis was conducted based on the number of live births.
IVF Outcomes Based on Serum AMH Levels
Subjects were identified from the database in three centers from January 2014 to October 2019 using the following inclusion and exclusion criteria. The inclusion criteria were set as follows: 1) female participants aged between 20 and 45 years, 2) participants with serum AMH measurement within 12 months before undergoing IVF/ICSI cycles. The participants were excluded if they met the following criteria: 1) participants who underwent pre-implantation genetic testing (PGT), 2) participants using donor semen or donor oocyte, 3) mixed transfers with embryos retrieved from different oocyte retrieval cycles, 4) women with severe chronic diseases, 5) women for whom main data were missing or who were lost to follow-up. The participants were categorized into three groups according to the <25th(low), 25th to 75th(average), and >75th(high) percentile of serum AMH concentration (0.01-1.76, 1.76-5.41, 5.41-25.00ng/ml). The subgroup analysis was conducted based on the number of live births.
Corresponding Organization : Chinese Academy of Medical Sciences & Peking Union Medical College
Other organizations : Suzhou Municipal Hospital, Nanjing Medical University
Variable analysis
- Serum AMH concentration (categorized into three groups: <25th (low), 25th to 75th (average), and >75th (high) percentile)
- Number of live births
- Female participants aged between 20 and 45 years
- Participants with serum AMH measurement within 12 months before undergoing IVF/ICSI cycles
- Exclusion of participants who underwent pre-implantation genetic testing (PGT)
- Exclusion of participants using donor semen or donor oocyte
- Exclusion of mixed transfers with embryos retrieved from different oocyte retrieval cycles
- Exclusion of women with severe chronic diseases
- Exclusion of women for whom main data were missing or who were lost to follow-up
- None specified
- None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!